Introduction: The loss of nigrosome-1 which is also referred to as the swallow tail sign (STS) in T2* weighted iron-sensitive magnetic resonance imaging (MRI) has recently emerged as a new biomarker for idiopathic Parkinson’s disease (IPD). However, consistent recognition of the STS is difficult due to individual variations and different imaging parameters. Radiomics might have the potential to overcome these shortcomings. Therefore, we chose to explore whether radiomic features of nigrosome-1 of substantia nigra (SN) based on quantitative susceptibility mapping (QSM) could help to differentiate IPD patients from healthy controls (HCs).
Methods: Three-dimensional multi-echo gradient-recalled echo images (0.86×0.86×1.00 mm3) were obtained at 3.0 T MRI for QSM in 87 IPD patients and 77 HCs. Regions of interest (ROIs) of the SN below the red nucleus were manually drawn on both sides, and subsequently, volumes of interest (VOIs) were segmented (these ROIs included 4 1mm slices). Then, 105 radiomic features (including 18 histogram features, 13 shape features, 74 texture features) of bilateral VOIs in the two groups were extracted. Forty features were selected according to the ensemble feature selection method which combined analysis of variance, random forest and recursive feature elimination. The selected features were further utilized to distinguish IPD patients from HC using SVM classifier with 10 rounds of 3-fold cross-validation. Finally, the representative features were analyzed using an unpaired t-test with Bonferroni correction and correlated with the UPDRS-III scores.
Results: The classification results from SVM were: area under curve (AUC): 0.96±0.02; accuracy: 0.88±0.03; sensitivity: 0.89±0.06; and specificity: 0.87±0.07. Five representative features were selected to show their detailed difference between IPD patients and HCs: 10 Percentile and Median in IPD patients were higher than those in HCs (all p
Read Full Article (External Site)
Dr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for the Success of Society. With a keen interest in exploring the untapped potential of the human mind, Dr. Lowemann has dedicated his career to pushing the boundaries of human capabilities and understanding.
Armed with a Master of Science degree and a Ph.D. in his field, Dr. Lowemann has consistently been at the forefront of research and innovation, delving into ways to optimize human performance, cognition, and overall well-being. His work at the Institute revolves around a profound commitment to harnessing cutting-edge science and technology to help individuals lead more fulfilling and intelligent lives.
Dr. Lowemann’s influence extends to the educational platform BetterSmarter.me, where he shares his insights, findings, and personal development strategies with a broader audience. His ongoing mission is shaping the way we perceive and leverage the vast capacities of the human mind, offering invaluable contributions to society’s overall success and collective well-being.